Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug store chains, food chains, hospitals, mass merchandisers, grocery chains, and other direct purchasers and customers, as well as healthcare institutions and private pharmacies. The company was founded in 1950 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. is a subsidiary of Alkaloida Chemical Company Exclusive Group Ltd.

Taro Pharmaceutical Industries Ltd.

Taro Pharmaceutical Industries is a research-based international pharmaceutical company that develops high-quality, proprietary and off-patent pharmaceuticals for markets in the US, Canada, Israel and other countries. The company emphasizes research and development as key to its growth strategy.

Taro Pharmaceutical Industries

Wellness and Fitness Services

Alchemee (formerly The Proactiv Company)

Pharmaceutical Manufacturing

TARO PHARMACEUTICALS CANADA

Taro Pharmaceuticals | 39,759 followers on LinkedIn. Established in 1950, Taro Pharmaceutical Industries Ltd. is a research-based, international, specialty pharmaceutical company that develops, manufactures and markets prescription and over-the-counter pharmaceutical products. Taro’s research programs and niche strategy have enabled the Company to achieve gross margins that are among the highest in the specialty pharmaceutical sector.

Avi Avramoff, R.Ph, Ph.D

Taro Pharmaceuticals

The Taro Generics team kicked off the summer with an outing to a Rockland Boulders game. The event was a fantastic opportunity for everyone to bond outside of work and strengthen our camaraderie. #TeamTaro

For over 50 years Taro Pharmaceuticals has manufactured Warfarin, a medication clinically shown to reduce the risk of death after myocardial infarction. Taro remains committed to manufacturing this and other lifesaving medications. Visit https://lnkd.in/d44_y6p5 for full prescribing information and medication guide.

Taro Pharmaceuticals is attending the National Association of Chain Drug Stores (NACDS) Annual Meeting this weekend. Stop by table 546 to meet with CEO Uday B. , VP of Generics Anthony Dolan , and VP of OTC Nivaran Kapur . We look forward to seeing you! #NACDSANNUAL #TeamTaro

On International Women’s Day, we would like to take this opportunity to reflect on the achievements and contributions of the women of Taro. Women make up 45% of our global workforce and hold nearly 50% of management level positions within the company. These numbers support Taro's aspiration to be an inclusive workplace where everyone feels valued, respected and has the opportunity to thrive. When we look at the data at a country level, the trend is similar: · In the United States, our workforce is nearly 50% women, and women hold 45% of management level positions. · In Israel, while women make up 44% of the workforce, they hold 57% of management level positions. · In Canada, 43% of our workforce are women, and they hold 46% of our management level positions. · In Japan, 61% of our workforce are women, and they hold 60% of management level positions. Additionally, women are strongly represented across our organization, even in fields that have been traditionally dominated by men. For example, globally women comprise 61% of our R&D/Regulatory/Clinical team, 66% of our Quality team, and 58% of our Supply Chain team. We are proud of the progress Taro has made in promoting gender equality and the advancement of women, and we will continue to work to ensure that Taro is a workplace where everyone has the opportunity to succeed and feels that they belong. #IWD2024 #InspireInclusion #TeamTaro

March is Blood Clot Awareness Month. Did you know that blood clots can affect anyone, anytime? This month, let's spread awareness and knowledge about the risks, signs, and preventive measures. #BCAM2024 #BCAM #TeamTaro

In recognition of American Heart Month, we were proud to partner with the Congenital Heart Defect Coalition to put together Kits of Hope for young children with heart defects who are awaiting treatment in hospitals across the country. Our Taro team members in Hawthorne, NY, assembled 100 kits that will be sent to the Children’s Hospital of Philadelphia, Children’s Hospital at Montefiore, Cohen Children’s Center, Northwell Health, Icahn School of Medicine at Mount Sinai, Boston’s Children’s Hospital and Columbia Medical Center. Thank you to our Taro volunteers for helping make a difference to these patients and their families! #TeamTaro

Taro Pharmaceuticals will be attending the National Association of Chain Drug Stores (NACDS) Annual Meeting in April. We look forward to seeing you there! #NACDSANNUAL #TeamTaro

Taro was honored to receive the Partnership in Quality Award at last week's GSMS, Incorporated annual STAR Summit. Congratulations to the team for this recognition!

msh id	COM:TARO
symbol	TARO
name	Taro Pharmaceutical Industries Ltd.
homepage url	https://www.taro.com
country	IL
sector	Healthcare
industry	Drug Manufacturers - Specialty & Generic
market	STOCKS
employee count	1.55K
crunchbase url	-
linkedin url	-
founders	-

market cap	1.62B
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	0.27
growth cost of revenue	0.14
growth depreciation and amortization	0.35
growth ebitda	-0.75
growth ebitda ratio	-0.75
growth eps	-
growth eps diluted	-
growth general and administrative expenses	0.49
growth gross profit	-0.08
growth gross profit ratio	-0.1

COM:TARO

Taro Pharmaceutical Industries

Last Close

42.97

21/06 19:59

Market Cap

1.62B

Beta: -

Volume Today

147.06K

Avg: -

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	555.24M
cost of revenue	555.24M
depreciation and amortization	34.94M
ebitda	52.65M
ebitda ratio	0.09
eps	0.68
eps diluted	0.68
operating expenses	250.61M
operating income	17.71M
operating income ratio	0.03

accounts receivables	37.48M
capital expenditure	-17.85M
cash at beginning of period	251.13M
cash at end of period	154.5M
inventory	226.67M
working capital ttm	973.35M

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-